Skip to content

Ventricular Tachycardia Ablation in LVAD Patients

Characterization of Ventricular Tachycardia Ablation in End-stage Heart Failure Patients With Left Ventricular Assist Device

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06063811
Acronym
CHANNELED
Enrollment
50
Registered
2023-10-03
Start date
2023-09-25
Completion date
2024-05-15
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Heart Failure, LVAD (Left Ventricular Assist Device), Ventricular Arrythmia, Ventricular Tachycardia

Keywords

Catheter Ablation, VT Ablation in LVAD patients

Brief summary

The CHANNELED-Registry is a multicenter retrospective study to (1) systematically assess the mechanism and origin of ventricular tachycardia in patients with end-stage heart failure carrying an left ventricular assist device (LVAD) and (2) to evaluate procedural parameters and outcome of ventricular tachycardia ablation in this special subset of patients.

Interventions

OTHERAblation

VT ablation

Sponsors

Universitätsklinikum Köln
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with end-stage heart failure with an LVAD implanted undergoing VT ablation

Exclusion criteria

* Patients \<18 years, pregnant women, patients undergoing VT ablation without an LVAD

Design outcomes

Primary

MeasureTime frameDescription
Heart failure Hospitalization (physiological parameter)12 monthAssessment of Hospitalization for worsening of Heart Failure after VT ablation.
Mechanism of ventricular tachycardia in LVAD patients (descriptive name of scale)12 monthAssessment of the mechanism of VT in LVAD patients (e.g LVAD cannula related vs. related to substrate of underlying heart disease)
Number of patients with ventricular tachycardia recurrence in device interrogation (physiological parameter)12 monthAssessment of VT recurrence after ablation: Device interrogation and readout of ICD Holter
Mortality (physiological parameter)12 monthAssessment of mortality after VT ablation.

Secondary

MeasureTime frameDescription
Procedure duration (From groin puncture to sheath removal in minutes)12 monthEvaluation of the duration of VT ablation procedures in LVAD patients
Fluoroscopy time (minutes)12 monthEvaluation of the fluroscopy use (in minutes)
Radiofrequency energy used for ablation (in watts; e.g. 40 Watts)12 monthEvaluation of the maximum RF-energy used for ablation
Number of patients suffering from intraprocedural complication (physiological parameter, e.g. hematoma)12 monthEvaluation of intraprocedural complications of VT ablation

Contacts

Primary ContactJakob Lüker, MD
jakob.lueker@uk-koeln.de+49 221 478 82851
Backup ContactJan-Hendrik van den Bruck, MD
jan-hendrik.van-den-bruck@uk-koeln.de+49 221 478 84895

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026